The health secretary said the injections are not 'cosmetic' treatments and should only be used by obese people who have ...
Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...
Some influencers are calling protein "nature's Ozempic." But can protein naturally stimulate your GLP-1 levels just like a ...
The Medicaid budget survey for fiscal years 2024 and 2025 revealed state predictions are expecting a decline in Medicaid ...
Add Alzheimer's disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new ...
Less than a week after the U.S. Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide ...
The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
The Medicaid rate hike will mitigate headwinds in that line of Molina Healthcare's business, which has seen higher costs ...
The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.
An analysis of over 400,000 patients with T1D revealed a rise in prescribing for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors over the past decade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback